Clinical Trial Update: Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of procaterol hydrochloride for cough variant asthma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough-variant Asthma

Drugs mentioned

• Procaterol Hydrochloride (procaterol hydrochloride)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Cough Variant Asthma | Phase 4 | Status: UNKNOWN